Full text is available at the source.
Abstract
Sodium oligomannate (GV-971) targets the gut-brain axis and may alleviate gliosis and cognitive dysfunction.
- Ischemic stroke is the second leading cause of death globally and has a limited treatment window for thrombolysis.
- Gut microbiota imbalances and gliosis are significant contributors to neurological impairment after ischemic stroke.
- GV-971 has shown promise in remodeling gut microbiota in Alzheimer's disease.
- The pharmacological effects of GV-971 on ischemic stroke remain unexamined.
Simplified